Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724385 | SCV000228472 | uncertain significance | not provided | 2015-01-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000189104 | SCV000242735 | benign | not specified | 2014-09-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001081126 | SCV000639638 | benign | Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy, 11 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345605 | SCV002651074 | likely benign | Inborn genetic diseases | 2017-12-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000724385 | SCV004147146 | benign | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | SCN2A: BS1, BS2 |